Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor
Senseonics Holdings, Inc. (SENS)
Last senseonics holdings, inc. earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
senseonics.com/investor-relations
Company Research
Source: GlobeNewswire
Senseonics’ Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by Ascensia Diabetes Care underway with a new campaign to highlight the unique benefits of having just one CGM for one full year GERMANTOWN, Md. and ST. LOUIS, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) (“Senseonics” or the “Company”), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, and Mercy, a leading healthcare system, today announced that the first commercial patient received the next-generation Eversense® 365 CGM system. This milestone, part of the company’s previously announced collaboration with Mercy, marks the world’s first commercial use of Eversense 365, the only CGM to provide one-year of accurate monitoring with minimal
Show less
Read more
Impact Snapshot
Event Time:
SENS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SENS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SENS alerts
High impacting Senseonics Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
SENS
News
- Senseonics Holdings, Inc. (NYSE: SENS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.MarketBeat
- Senseonics Holdings, Inc. to Participate in Upcoming Investor ConferencesGlobeNewswire
- Senseonics Holdings Inc (SENS) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... [Yahoo! Finance]Yahoo! Finance
- Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial ResultsGlobeNewswire
- Earnings To Watch: Senseonics Holdings Inc (SENS) Reports Q3 2024 Result [Yahoo! Finance]Yahoo! Finance
SENS
Earnings
- 11/7/24 - Miss
SENS
Analyst Actions
- 11/15/24 - HC Wainwright
SENS
Sec Filings
- 11/8/24 - Form D
- 11/7/24 - Form 10-Q
- 11/7/24 - Form 8-K
- SENS's page on the SEC website